IDEXX LABORATORIES INC /DE is 29.3x more valuable than Anbio Biotechnology by market capitalization ($43.93 B vs $1.50 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IDXX | NNNN |
|---|---|---|
| Market cap | $43.93 B | $1.50 B |
| US-listed rank | #351 | #2315 |
| Revenue (latest FY) | $4.30B | $8.65M |
| Net income (latest FY) | $1.06B | $6.40M |
| Net margin | 24.6% | 74.1% |
| P/E (trailing FY) | 41.5 | 234.2 |
| SEC filings | 2,148 | 40 |
IDEXX LABORATORIES INC /DE is 29.3x more valuable than Anbio Biotechnology by market capitalization ($43.93 B vs $1.50 B).
In their latest fiscal years, IDEXX LABORATORIES INC /DE reported $4.30B in revenue while Anbio Biotechnology reported $8.65M.
Full pages: IDEXX LABORATORIES INC /DE and Anbio Biotechnology, or browse the full rankings.